Israeli Company’s Bone Marrow Transplant Drug Approved for Human Testing

Israel’s Cell Source Inc., an immunotherapy and regenerative medicine company, announced that its Megadose Drug Combination which assists in bone marrow transplants has been cleared for human clinical More...